Zaganjor Ibrahim, Sekkarie Ahlia, Tsang Becky L, Williams Jennifer, Razzaghi Hilda, Mulinare Joseph, Sniezek Joseph E, Cannon Michael J, Rosenthal Jorge
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Carter Consulting Inc., Atlanta, Georgia, United States of America.
PLoS One. 2016 Apr 11;11(4):e0151586. doi: 10.1371/journal.pone.0151586. eCollection 2016.
Folate-sensitive neural tube defects (NTDs) are an important, preventable cause of morbidity and mortality worldwide. There is a need to describe the current global burden of NTDs and identify gaps in available NTD data.
We conducted a systematic review and searched multiple databases for NTD prevalence estimates and abstracted data from peer-reviewed literature, birth defects surveillance registries, and reports published between January 1990 and July 2014 that had greater than 5,000 births and were not solely based on mortality data. We classified countries according to World Health Organization (WHO) regions and World Bank income classifications. The initial search yielded 11,614 results; after systematic review we identified 160 full text manuscripts and reports that met the inclusion criteria. Data came from 75 countries. Coverage by WHO region varied in completeness (i.e., % of countries reporting) as follows: African (17%), Eastern Mediterranean (57%), European (49%), Americas (43%), South-East Asian (36%), and Western Pacific (33%). The reported NTD prevalence ranges and medians for each region were: African (5.2-75.4; 11.7 per 10,000 births), Eastern Mediterranean (2.1-124.1; 21.9 per 10,000 births), European (1.3-35.9; 9.0 per 10,000 births), Americas (3.3-27.9; 11.5 per 10,000 births), South-East Asian (1.9-66.2; 15.8 per 10,000 births), and Western Pacific (0.3-199.4; 6.9 per 10,000 births). The presence of a registry or surveillance system for NTDs increased with country income level: low income (0%), lower-middle income (25%), upper-middle income (70%), and high income (91%).
Many WHO member states (120/194) did not have any data on NTD prevalence. Where data are collected, prevalence estimates vary widely. These findings highlight the need for greater NTD surveillance efforts, especially in lower-income countries. NTDs are an important public health problem that can be prevented with folic acid supplementation and fortification of staple foods.
叶酸敏感性神经管缺陷(NTDs)是全球发病和死亡的一个重要且可预防的原因。有必要描述当前全球NTDs的负担,并找出现有NTD数据中的差距。
我们进行了一项系统综述,在多个数据库中搜索NTD患病率估计值,并从同行评审文献、出生缺陷监测登记处以及1990年1月至2014年7月期间发表的报告中提取数据,这些报告的出生人数超过5000,且并非仅基于死亡率数据。我们根据世界卫生组织(WHO)区域和世界银行收入分类对国家进行分类。初步搜索产生了11614条结果;经过系统综述,我们确定了160篇符合纳入标准的全文手稿和报告。数据来自75个国家。按WHO区域划分的覆盖完整性(即报告国家的百分比)如下:非洲(17%)、东地中海(57%)、欧洲(49%)、美洲(43%)、东南亚(36%)和西太平洋(33%)。各区域报告的NTD患病率范围和中位数分别为:非洲(5.2 - 75.4;每10000例出生11.7例)、东地中海(2.1 - 124.1;每10000例出生21.9例)、欧洲(1.3 - 35.9;每10000例出生9.0例)、美洲(3.3 - 27.9;每10000例出生11.5例)、东南亚(1.9 -